Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Receives Formulation Patent Notice of Allowance
21 août 2019 14h41 HE | Intrommune Therapeutics
New York, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Receives Best Private Company Presentation Award at BioNJ’s 9th Annual BioPartnering Conference
17 mai 2019 13h25 HE | Intrommune Therapeutics
New York, May 17, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing patient-friendly food allergy therapies for peanut and other food allergies...
RITA & ALEX HILLMAN FOUNDATION ANNOUNCES ITS LARGEST-EVER GRANT TO A SINGLE NURSING-DRIVEN INNOVATION
11 déc. 2018 11h00 HE | The Rita & Alex Hillman Foundation
New York, NY, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Affirming its commitment to developing and disseminating innovative models of care that meet the needs of vulnerable and underserved people, the Rita...
Capsule
Convexity Scientific Announces New Partnership
10 oct. 2018 05h00 HE | Convexity Scientific Inc.
NEW YORK, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Convexity Scientific, a growing health and wellness startup headquartered in Fairfield, Connecticut, today announced an agreement with Capsule that will...
desc
2014 OPEN MINDS Planning & Innovation Institute Zeroes In On Market Positioning - ACOs, Medical Homes, Capitation, & More
17 déc. 2013 09h20 HE | Open Minds
NEW ORLEANS, LA., Dec. 17, 2013 (GLOBE NEWSWIRE) -- OPEN MINDS announced that the fourth annual OPEN MINDS Planning & Innovation Institute will take place on June 3-5, 2014 at the Sheraton in New...